Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease.
Apolipoprotein E 4 (ApoE 4) has been linked to pathogenesis of Alzheimer's disease and has been suggested to be maintained through evolutionary pressure via a protective role in malaria infection. We evaluated Plasmodium falciparum viability at the intraerythrocyte stage by exposure to plasma from human subjects with ApoE 4/4 or ApoE 3/3. Plasma samples from ApoE 4/4 but not ApoE 3/3 donors inhibited growth and disrupted morphology of P. falciparum. Evolutionary history is characterized by war between pathogenic microorganisms and defense mechanisms countering their pathogenicities. ApoE 4 frequency is highest in sub-Saharan Africa and other isolated populations (e.g., Papua New Guinea) that exhibit endemic malaria. High ApoE frequency may offer selective advantage protecting against some infectious diseases (e.g., Plasmodium falciparum). These results implicate evolutionary pressure by malaria selecting humans with ApoE 4/4, even considering lower survival in late life. These selective advantages may be relevant in the exploration of possible disparities between Black and Whites in the incidence of Alzheimer's Disease.
Hisashi
H
Fujioka
Clyde F
CF
Phelix
Robert P
RP
Friedland
Xiongwei
X
Zhu
Elizabeth A
EA
Perry
Rudy J
RJ
Castellani
George
G
Perry
D000544:Alzheimer Disease / Q000235:genetics; D053318:Apolipoprotein E3 / Q000097:blood / Q000502:physiology; D053327:Apolipoprotein E4 / Q000097:blood / Q000502:physiology*; D002478:Cells, Cultured; D004912:Erythrocytes / Q000469:parasitology*; D006801:Humans; D008854:Microscopy, Electron; D010963:Plasmodium falciparum / Q000254:growth & development* / Q000469:parasitology
D053318:Apolipoprotein E3; D053327:Apolipoprotein E4